| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |